Fundraising Fox
/People
Sign in

Aymeric Sallin

Investor

Founder & Chief Executive Officer at +ND Capital · Board director at Tarveda Therapeutics · Board director at Cartesian Therapeutics (NASDAQ: RNAC)

Menlo Park, California

Writes $100K – $5M checks · typically $1.5M

Find your path to Aymeric

121 people in our graph share verified history with Aymeric — schools, employers, funds. One of them is your warm intro.

Ziv PazunlockedAymeric: together at Crocus Technology (2020–2021)
×2Aymeric: together at Tarveda Therapeutics
Aymeric: together at H55
×3Aymeric: together at Selecta Biosciences

About

Founded +ND Capital in 2002 after nanotechnology research at EPFL; a former Bain & Company strategy consultant, he splits time between Switzerland and the US and sits on several portfolio boards. He is a WEF Young Global Leader (2013) and holds a Masters in Physical Engineering from EPFL.

Contact· published on Aymeric's own website

Invests in

AI & Machine LearningBiotechDeep TechEnergyHardwareMedical Devices

Board director at Tarveda Therapeutics

Intro paths

→

In turn, Aymeric can intro founders to Tarveda Therapeutics's investors below.

Tarveda Therapeutics's investors · 3

+ND CapitalWoodside · $540K – $5.4M checks · since 2012Kendall Capital PartnersBoston · since 2016New Enterprise Associates (NEA)Menlo Park · $200K – $40M checks

Co-founders at Tarveda Therapeutics

OFOmid Farokhzad
Omid FarokhzadDirector
RSRobert S. Langer, Jr.
Robert S. Langer, Jr.Director
OCOmid C. Farokhzad
Omid C. FarokhzadDirector
RSRobert S. Langer
Robert S. LangerDirector

Board director at Cartesian Therapeutics (NASDAQ: RNAC)

Intro paths

→

In turn, Aymeric can intro founders to Cartesian Therapeutics (NASDAQ: RNAC)'s investors below.

Cartesian Therapeutics (NASDAQ: RNAC)'s investors · 8

+ND CapitalWoodside · $540K – $5.4M checksK2 HealthVenturesBoston · $10M – $100M checksMaryland TEDCOColumbia · $500K – $1.5M checksNational Institutes of Health (NIH)since 2018Polaris PartnersBoston · $500K – $5M checks · since 2016RUSNANOMoscowSchooner CapitalBostonTEDCOColumbia

Co-founders at Cartesian Therapeutics (NASDAQ: RNAC)

MK
Metin KurtogluExecutive Officer
OF
Omid FarokhzadDirector

Experience

  1. NanoDimensionFounder and CEOcurrent2002 — present
  2. H55Board Membercurrent2018 — presentSion, Switzerland
  3. EPFL (École polytechnique fédérale de Lausanne)Member of the Strategic Advisory Boardcurrent2014 — present
  4. EPFL (École polytechnique fédérale de Lausanne)Advisory Board Member of the Physique facultycurrent2008 — present
  5. EPFL (École polytechnique fédérale de Lausanne)Chairman of the Board of Alumni2014 — 2023
  6. Natron EnergyBoard Member2019 — 2024Santa Clara, California, United States
  7. Selecta BiosciencesBoard Member2009 — 2024
  8. Crocus TechnologyBoard Member2006 — 2023
  9. Tarveda TherapeuticsBoard Member2011 — 2022Cambridge, USA
  10. View, Inc.Board Member2012 — 2018Milpitas CA
  11. Bain & CompanyStrategy Consultant2000 — 2001
  12. Sein & ScheinCo-Founder1995 — 1998

Skills & more

Venture Capital25Investments12Technology Transfer16Nanotechnology28Start-ups37Entrepreneurship31Fundraising7Semiconductors7

From Aymeric's professional profile.

Investments

Investor

BIND TherapeuticsCrocus TechnologyH55Selecta BiosciencesTarveda TherapeuticsView

Per curated public sources.

Colleagues at +ND Capital

Aditya Rajagopal
Venture Partner at +ND Capital
Alison Palmer
Vice President of the General Partner at +ND Capital
André Châtelain
Advisor at +ND Capital
Carl Pabo
Advisor at +ND Capital
Cathleen O’Connor
Executive Assistant at +ND Capital
Eric Moessinger
Partner at +ND Capital
Gabriela Ecco
Principal at +ND Capital
Jonathan Nicholson
Executive Director of the General Partner at +ND Capital

Network6

Bill GatesScout
Co-founder of Microsoft; Chair of the Gates Foundation
Alison Palmer
Vice President of the General Partner at +ND Capital
Amir Nashat
Entrepreneur partner at Polaris Partners focused on healthcare investing and portfolio company executive roles
Gabriela Ecco
Principal at +ND Capital
Kirill Kuzmichev
Principal at +ND Capital
Klaus Dugi
Chief Medical Advisor & Venture Partner at +ND Capital

Investors connected to Aymeric in public investor directories — a warm-intro map.

Frequently asked questions

Who is Aymeric Sallin?
Founded +ND Capital in 2002 after nanotechnology research at EPFL; a former Bain & Company strategy consultant, he splits time between Switzerland and the US and sits on several portfolio boards. He is a WEF Young Global Leader (2013) and holds a Masters in Physical Engineering from EPFL.
Where does Aymeric Sallin work?
Aymeric Sallin is Founder & Chief Executive Officer at +ND Capital and Board director at Tarveda Therapeutics and Board director at Cartesian Therapeutics (NASDAQ: RNAC).
What does Aymeric Sallin invest in?
Aymeric Sallin invests in AI & Machine Learning, Biotech, Deep Tech, Energy, Hardware, Medical Devices.
What check size does Aymeric Sallin write?
Aymeric Sallin typically writes checks of $100K – $5M.
What companies has Aymeric Sallin invested in?
Investments tracked here include BIND Therapeutics, Crocus Technology, H55, Selecta Biosciences, Tarveda Therapeutics, View.
Where did Aymeric Sallin go to school?
Aymeric Sallin studied at EPFL (MSc., Physics).

Same school

Shared employers